logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Lee’s Pharm Forms Second China Cancer Partnership with Beijing Shenogen

Nov 22, 2017

Life Science

NAI500 Investment Destination Series – Learn about Investment in Vancouver Part 3: Life Science Sector

Nov 2, 2017

Life Science, Technology

NAI500 Life Science & Technology Weekly Issue 119 – AU, China’s ZTE Launch Smart Health System Project

Nov 2, 2017

Life Science, Technology

NAI500 Investment Destination Series Part 1 - learn about investment in Vancouver - China investment - Chinese investors

NAI500 Investment Destination Series – Learn about Investment in Vancouver Part 1

Oct 26, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Disruptive Technology for Improved Delivery of Bioactive Compounds

Aug 29, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

A Canadian Hemp Company Steps into Asia Market

Apr 10, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Interviews with Jon Stern, CEO of Cohbar Inc.

Dec 15, 2015

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Disrupting Treatment of Cardiovascular Disease with Epigenetics: Resverlogix CEO Donald McCaffrey

Oct 20, 2015

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

  • ‹‹ Previous
  • 174
  • 175
  • 176
  • 177
  • 178

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada